Will Banco Santander SA Make An Offer For Monitise Plc?

Monitise Plc (LON: MONI) looks like a great acquisition for Banco Santander SA (LON: BNC).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Mobile money company Monitise (LSE: MONI) put itself up for sale several weeks ago but, so far, no buyer has emerged. But it looks as if European banking giant Santander (LSE: BNC) could be the perfect suitor for the company.

You see, there’s not much value left in Monitise’s business model. The company continues to lose money hand over fist. However, there is value in the company’s existing relationships with banks. One of these banks is Santander. 

What’s more, Santander is looking to increase its own digital presence. Indeed, Santander has 92m retail customers globally, of which only 12.2m do most of their banking with Santander.

Management has stated that it wants to hike this figure to 17m by 2017, which the bank believes could add €2bn to €3bn of additional income.

Then there’s Monitise’s partnership with IBM to consider.

Value in the cloud

In order to reassure customers about the security of their online accounts, Santander is to be the first global bank to offer cloud data storage services to corporate clients. As one of the world’s largest tech companies with a huge presence in the cloud computing sector, IBM could be a key partner for Santander’s cloud development — IBM could be considered to be another bidder for Monitise.

Still, as mentioned above, Monitise already has a number of valuable relationships with European banks and other large corporate clients, which would give Santander a huge base from which to sell its new cloud offering. If Santander snaps up Monitise for itself, Europe’s largest bank could quickly find itself the data- and payment-processing company of choice for large financial institutions around Europe. This would align with the bank’s goal of become more digitally orientated and expand the group’s influence.

Time to buy

Should investors buy Monitise ahead of a possible deal? Well, buying in the expectation of a possible takeover is often a fool’s errand. There’s no guarantee that this time it’ll be any different.

Moreover, Monitise is struggling to turn a profit and the company’s losses are only increasing. For example, the company’s fiscal first-half 2015 results showed that group revenue had fallen to £42.4m, from £46.5m during the first half of 2014. The company’s statutory loss after tax rose to £56.8m compared to a loss of £22.0m as reported in the year-ago period.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns shares of International Business Machines. The Motley Fool UK owns shares of Monitise. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

The Rolls-Royce share price hit new highs in November. What next?

November has been another record-breaking month for the Rolls-Royce share price. And the outlook for 2025 still looks bright.

Read more »

Investing Articles

Here’s the growth forecast for Sage Group shares to 2026!

Sage Group shares have rocketed following the tech firm's stunning third-quarter update. Is now the time to consider buying in?

Read more »

Investing Articles

10%+ dividend growth! 2 FTSE 250 shares tipped to turbocharge dividends

These FTSE 250 income shares look in great shape to grow their dividends by double-digit percentages, says our writer Royston…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Investing Articles

Would it be madness to buy this FTSE stock smashed by Donald Trump’s team picks?

Ben McPoland takes a look at one FTSE share inside his portfolio that has been battered lately due to a…

Read more »

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »